期刊文献+

缺血再灌注损伤促进裸鼠肝癌生长及癌旁组织VEGF和MMP-9表达 被引量:3

Ischemia-reperfusion promotes hepatic cancer growth and expression of VEGF and MMP-9 in adjacent tissues of cancer in nude mice
下载PDF
导出
摘要 目的:观察缺血再灌注损伤对裸鼠肝癌生长及癌旁组织转移复发相关基因(VEGF、MMP-9)表达的影响。方法:将人肝癌细胞Hep3B原位种植于裸鼠肝脏制备荷肝癌裸鼠模型,荷瘤裸鼠随机分为缺血再灌注后1 h、6 h、5 d、7 d及假手术组(n=8),缺血再灌注组荷肝癌裸鼠采用肝门阻断法制备缺血再灌注损伤模型,假手术组不阻断肝门血供.其余同缺血再灌注组。缺血再灌注后1 h、6 h检测裸鼠肝功能(ALT、AST)的变化(n=8);实时荧光定量PCR检测瘤旁组织VEGF和MMP-9 mRNA的表达,并与正常对照组作比较(n=6)。缺血再灌注后5 d、7 d取肝组织,H—E染色观察肝组织病理学变化,计算肿瘤周边变性坏死区域(n=6)。剩余荷瘤裸鼠于缺血再灌注后2周处死取肿瘤,测定缺血再灌注组及假手术组裸鼠肿瘤体积及质量。结果:术后2周缺血再灌注组肿瘤体积(mm^3)及质量(g)明显高于假手术组[(209.6±25.74)vs(330.6±32.01).(0.214±0.036)vs(0.374±0.045),P<0.01]。缺血再灌注后1、6 h裸鼠血浆ALT和AST增高,明显高于假手术组(P<0.01)。H-E染色结果表明再灌注后5 d肿瘤周边组织炎症细胞浸润、变性坏死区域较假手术组更明显(P<0.05);再灌注后7 d肿瘤周边变性坏死区域较5 d减少(P<0.05),但变性坏死区域被肿瘤细胞浸润代替。荧光定量结果表明,缺血再灌注后1 h和6 h癌旁组织VEGF和MMP-9 mRNA表达明显高于假手术组(P<0.01)。且二者表达具有一定相关性(r=0.418,P<0.01)。结论:肝门阻断所导致的缺血再灌注损伤加速了裸鼠肝肿瘤细胞的生长,促进了癌旁组织中与转移复发相关基因(VEGF、MMP-9)的表达。 Objective:To observe the influence of ischemia-reperfusion (I/R) on hepatoma growth and on the expression of genes associated with tumor metastasis and recurrence (VEGF and MMP-9) in the adjacent tissues of cancer in nude mice. Methods: BALB/c nude mouse model bearing Hep3B-tumor in the liver was established and the model mice were evenly randomly into 5 groups: sham group and ischemia/reperfusion 1 h, 6 h, 5 d, and 7 d groups (n=8). I/R models were established by blocking porta hepatic; the sham group underwent the same treatment as the I/R model group except for blocking of porta hepatic. ALT and AST were detected in I/R 1 h and 6 h groups. Real-time-PCR was employed to detect the change of VEGF and MMP-9 in the adjacent tissues of cancer and the results were compared with that of the control group (n = 6). Histopathological changes of liver were studied by H-E staining and necrotic areas were calculated in I/R 5 d and 7 d groups (n=6). The remnant tumor bearing mice were sacrificed 2 weeks after I/R to measure the volume and mass of the tumors. Results: Two weeks later, the tumor volume and mass in I/R group were increased compared with those in the sham group ([209.6±25.74] mm^3 vs[330.6±32.01] mm3 ,[0. 214±0. 036] g vs [0. 374±0. 045] g, P〈0.01). Levels of ALTandAST were significantly elevated in I/R 1 h and 6 h groups compared with those in the sham group (P〈0.01). H-E staining showed that the infiltration of inflammatory cells around the tumors and the areas of necrosis became more prominent 5 days after I/R compared with the sham operation group (P〈0.05). The necrosis area was reduced 7 days after I/R compared with 5 days after I/R (P〈 0. 05); however, the necrosis area was replaced by invasion of tumor cells (P〈 0. 05). It was found that the expression of VEGF and MMP-9 mRNA was higher in the adjacent tissues of cancer after I/R than that in the sham group (P〈 0.01), and the expression of the 2 was correlated with each other (r=0. 418, P〈0.01). Conclusion: I/R induced by blocking porta hepatic can accelerate tumor cell growth and promote expression of VEGF and MMP-9 in the adjacent tissues of cancer.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2008年第5期495-498,共4页 Academic Journal of Second Military Medical University
基金 国家自然科学基金(30772512)~~
关键词 肝肿瘤 缺血再灌注 VEGF MMP-9 liver cancer ischemia/reperfusion VEGF MMP-9
  • 相关文献

参考文献11

  • 1de-Boer M T, Molenaar I Q, Porte R J. Impact of blood loss on outcome after liver resection[J]. Dig Surg, 2007,24:259-264.
  • 2Tsuruma T, Sahara H, Takenouchi M, Yagihashi A, Iwayama Y, Shima H, et al. Synthetic sulfonolipids deduced from sulfono quinovosyl diacylglycerols of sea urchin reduces hepatic ischemia-reperfusion injury in rats[J]. Transplant Proc, 2004,36 : 1965- 1969.
  • 3Chouker A, Martignoni A, Sehauer R, Dugas M, Rau H G, Jaueh K W, et al. Beneficial effects of ischemic preconditioning in patients undergoing hepatectomy:the role of neutrophils[J]. Arch Surg, 2005,140 : 129-136.
  • 4赵佐庆,陈洪茂.肝癌组织和正常肝组织缺血再灌注损伤的比较研究[J].中国普通外科杂志,2005,14(7):497-500. 被引量:7
  • 5Nicoud I B,Jones C M,Pierce J M,Earl T M,Matrisian L M, Chari R S, et al. Warm hepatic ischemia-reperfusion promotes growth of colorectal carcinoma micrometastases in mouse liver via matrix metalloproteinase-9 induction[J]. Cancer Res,2007, 67:2720-2728.
  • 6Sahin A, Kiratli H, Soylemezoglu F, Tezel G G, Bilgic S, Saracbasi O. Expression of vascular endothelial growth factor A,ma trix metalloproteinase-9,and extravascular matrix patterns and their correlations with clinicopathologic parameters in posterior uveal melanomas[J]. Jpn J Ophthalmol, 2007,51 : 325-331.
  • 7van-der-Bilt J D, Kranenburg O, Nijkamp M W, Smakman N, Veenendaal L M,Te-Velde E A, et al. Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model[J]. Hepatology,2005,42 :165-175.
  • 8McCormack L,Petrowsky H, Clavien P A. Surgical therapy of hepatocellular carcinoma [J]. Eur J Gastroenterol Hepatol, 2005,17:497-503.
  • 9Sun H C,Tang Z Y. Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives[J]. J Cancer Res Clin Oncol, 2004,130 : 307-319.
  • 10Zhang Q, Chen X, Zhou J,Zhang L, Zhao Q, Chen G, et al. CD147 ,MMP-2 ,MMP-9 and MVD-CD34 are significant predictors of recurrence after liver transplantation in hepatocellular carcinoma patients[J]. Cancer Biol Ther, 2006,5 : 808-814.

二级参考文献22

  • 1吕新生,胡国璜,李小刚.缺血预处理在原发性肝癌切除手术中的应用[J].中国普通外科杂志,2004,13(9):679-681. 被引量:2
  • 2肖刚,张文敏,张萌,谢丹,郭爱林,文剑明.人肝癌组织中iNOS、VEGF的表达及微血管密度的病理意义[J].癌症,2005,24(1):99-103. 被引量:13
  • 3Sun H C, Tang Z Y. Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives [J]. J Cancer Res Clin Oncol, 2004, 130(6):307-319.
  • 4Ishii Y, Nakasato Y, Kobayashi S, et al. A study on angiogenesis-related matrix metalloproteinase networks in primary hepatocellular carcinoma [J]. J Exp Clin Cancer Res, 2003,22(3) :461-470.
  • 5Sakamoto Y, Mafune K, Mori M, et al. Overexpression of MMP-9 correlates with growth of small hepatocellular carcinoma [J]. Int J Oncol, 2000, 17(2) :237-243.
  • 6Chao Y, Li C P, Chau G Y, et al. Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with respectable hepatocellular carcinoma after surgery [J]. Ann Surg Oncol,2003,10(4) :355-362.
  • 7Maatta M, Soini Y, Liakka A, et al. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma:implications for tumor progresion and clinical prognosis[J].Clin Cancer Res,2000.6(7):2726-2734.
  • 8An F Q, Matsuda M, Fujii H, et al. Expression of vascular endothelial growth factor in surgical specimens of hepatocellular carcinoma [J]. J Cancer Res Clin Oncol, 2000, 126(3) : 153-160.
  • 9Moon W S, Rhyu K H, Kang M J, et al. Overexpression of VEGF and angiopoietin 2: a key to high vascularity of hepatocellular carcinoma? [J]. Mod Pathol, 2003, 16(6) :552-557.
  • 10Unemori E N, Ferrara N, Bauer E A, et al. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells [J]. J Cell Physiol,1992,153(3) :557-562.

共引文献40

同被引文献58

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部